172 related articles for article (PubMed ID: 37330390)
1. Monoclonal gammopathy of uncertain significance.
Alejo E; Puertas B; Mateos MV
Med Clin (Barc); 2023 Sep; 161(5):217-224. PubMed ID: 37330390
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal gammopathy of renal significance: Early diagnosis is key.
Alonso-Titos J; Martínez-Esteban MD; López V; León M; Martin-Reyes G; Ruiz-Esteban P; Hernández D
Nefrologia (Engl Ed); 2021; 41(5):502-513. PubMed ID: 36165133
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI; Rajkumar SV
Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
[TBL] [Abstract][Full Text] [Related]
4. Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: A rare finding.
Saijpaul R; Khurana V; Verma R; Kaushik S
Indian J Pathol Microbiol; 2024; 67(1):192-194. PubMed ID: 38358220
[TBL] [Abstract][Full Text] [Related]
5. Does my patient with a serum monoclonal spike have multiple myeloma?
Bianchi G; Ghobrial IM
Hematol Oncol Clin North Am; 2012 Apr; 26(2):383-93, ix. PubMed ID: 22463833
[TBL] [Abstract][Full Text] [Related]
6. [Pitfalls of monoclonal gammopathy].
Meuleman N
Rev Med Brux; 2013 Sep; 34(4):335-8. PubMed ID: 24195249
[TBL] [Abstract][Full Text] [Related]
7. When a Monoclonal Gammopathy Is Not Multiple Myeloma.
Derman B; Castillo JJ; Sarosiek S; Beksac M
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-10. PubMed ID: 35394823
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
[TBL] [Abstract][Full Text] [Related]
9. Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report.
Movilla Echeverri C; Montilla Cosano G; Rivera Garrido C; Suñer Poblet M; Suarez Benjumea A
Transplant Proc; 2023 Dec; 55(10):2301-2303. PubMed ID: 38030424
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomes.
Garderet L; Al Hariri M; Wasielica-Poslednik J; Munder M; Kormányos K; Pena C; Gozzetti A; Zhou X; Waszczuk-Gajda A; Rosinol L; Mikala G; Krzystanski M; Lisch W; Vesole D; Szentmáry N; Jurczyszyn A
Leuk Lymphoma; 2022 Apr; 63(4):984-990. PubMed ID: 34823428
[TBL] [Abstract][Full Text] [Related]
11. Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.
Nador G; Ramasamy K; Panitsas F; Pratt G; Sadler R; Javaid MK
Rheumatology (Oxford); 2019 Jul; 58(7):1142-1153. PubMed ID: 31225884
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathy and rheumatic diseases.
Raposo A; Peixoto D; Bogas M
Acta Reumatol Port; 2014; 39(1):12-8. PubMed ID: 24811457
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
14. AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of "monoclonal gammopathy of inflammatory significance"?
Terré A; Colombat M; Cez A; Martin C; Diet C; Brechignac S; Oghina S; Bodez D; Faguer S; Savey L; Galland J; Boffa JJ; Grateau G; Jaccard A; Buob D; Georgin-Lavialle S
Int J Clin Pract; 2021 Nov; 75(11):e14817. PubMed ID: 34490695
[TBL] [Abstract][Full Text] [Related]
15. Screening for and diagnosis of monoclonal gammopathy.
Chong YP; Lim SM; Loh TP; Mollee P; Wijeratne N; Choy KW
J Clin Pathol; 2023 Nov; 76(11):727-733. PubMed ID: 37604683
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA
Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
Ho M; Zanwar S; Buadi FK; Ailawadhi S; Larsen J; Bergsagel L; Binder M; Chanan-Khan A; Dingli D; Dispenzieri A; Fonseca R; Gertz MA; Gonsalves W; Go RS; Hayman S; Kapoor P; Kourelis T; Lacy MQ; Leung N; Lin Y; Muchtar E; Roy V; Sher T; Warsame R; Fonder A; Hobbs M; Hwa YL; Kyle RA; Rajkumar SV; Kumar S
Blood; 2022 Nov; 140(18):1997-2000. PubMed ID: 36096078
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy of unknown significance: Implications of Indian baseline data.
Joshi K; Singh S
Natl Med J India; 2021; 34(6):376-378. PubMed ID: 35818096
[No Abstract] [Full Text] [Related]
19. Monoclonal gammopathies of undetermined significance.
Kyle RA; Rajkumar SV
Rev Clin Exp Hematol; 2002 Sep; 6(3):225-52. PubMed ID: 12616697
[TBL] [Abstract][Full Text] [Related]
20. Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.
Kleinstern G; Larson DR; Allmer C; Norman AD; Muntifering G; Sinnwell J; Visram A; Rajkumar V; Dispenzieri A; Kyle RA; Slager SL; Kumar S; Vachon CM
Blood Cancer J; 2022 Apr; 12(4):67. PubMed ID: 35440099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
